Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

GGHCX vs. JEHSX: which is better?

Bottom line

GGHCX vs JEHSX: the short answer

GGHCX (INVESCO Health Care Fund) and JEHSX (Health Sciences Trust) share a meaningful slice of their top holdings — about 59% by weight.

But JEHSX is far broader, holding 173 positions to 82 for GGHCX, so beyond the top names it adds exposure GGHCX doesn't have.

JEHSX is cheaper at 1.04% vs 1.07% — a difference of $3.00 a year per $10,000 invested.

Over five years, JEHSX returned +4.2% a year vs +2.6% for GGHCX.

GGHCX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

GGHCX vs JEHSX side by side

GGHCXJEHSX
TypeMutual fundMutual fund
Fund familyInvescoJohn Hancock
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.07%1.04%
Annual cost per $10k$107$104
10-yr cost on $10k (prospectus)$1,784$1,282
Max front load5.5%—
12b-1 fee0.25%0.05%
1-yr return+9.2%+19.5%
5-yr return (annualized)+2.6%+4.2%
10-yr return (annualized)+5.8%+8.7%
Best quarter+19.6%+23.6%
Worst quarter−16.5%−16.1%
Net assets (fund)$1.2B$251.3M
Number of holdings82173
Portfolio turnover59%68%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearGGHCXJEHSXDifference
2025+15.5%+19.5%−4.0%
2024+4.0%+1.8%+2.2%
2023+3.1%+4.3%−1.2%
2022−13.5%−13.1%−0.4%
2021+12.2%+11.2%+1.0%
2020+14.5%+27.2%−12.7%
2019+32.0%+28.7%+3.3%
2018+0.5%+0.7%−0.2%
2017+15.5%+27.5%−12.1%
2016−11.7%−10.6%−1.1%

Source: Fund prospectus bar charts

Holdings overlap

12 of GGHCX's top 25 holdings also appear in JEHSX's top 25.

Shared top holdings
HoldingGGHCXJEHSX
Eli Lilly and Co.10.59%14.30%
Johnson & Johnson6.76%6.33%
UnitedHealth Group Inc.6.17%5.95%
Merck & Co., Inc.4.59%4.21%
AbbVie Inc.4.03%5.28%
Gilead Sciences, Inc.3.63%2.95%
CVS Health Corp.2.52%0.98%
BrightSpring Health Services, Inc.2.20%0.88%
Cardinal Health, Inc.2.10%1.09%
Guardant Health, Inc.2.04%1.28%
Vertex Pharmaceuticals Inc.2.01%2.38%
Thermo Fisher Scientific Inc.1.55%2.67%

Source: SEC Form N-PORT

GGHCX top 10

  1. Eli Lilly and Co. — 10.59%
  2. Johnson & Johnson — 6.76%
  3. UnitedHealth Group Inc. — 6.17%
  4. Invesco Private Prime Fund — 4.67%
  5. Merck & Co., Inc. — 4.59%
  6. AbbVie Inc. — 4.03%
  7. Gilead Sciences, Inc. — 3.63%
  8. argenx SE — 3.24%
  9. CVS Health Corp. — 2.52%
  10. Welltower Inc. — 2.34%

JEHSX top 10

  1. Eli Lilly and Company — 14.30%
  2. Johnson and Johnson — 6.33%
  3. UnitedHealth Group Incorporated — 5.95%
  4. AbbVie Inc. — 5.28%
  5. Merck and Co. Inc. — 4.21%
  6. Gilead Sciences Inc. — 2.95%
  7. Thermo Fisher Scientific Inc. — 2.67%
  8. Vertex Pharmaceuticals Incorporated — 2.38%
  9. Bristol-Myers Squibb Company — 2.22%
  10. Abbott Laboratories — 2.00%

FAQ

What is the difference between GGHCX and JEHSX?
GGHCX (INVESCO Health Care Fund) and JEHSX (Health Sciences Trust) share a meaningful slice of their top holdings — about 59% by weight. But JEHSX is far broader, holding 173 positions to 82 for GGHCX, so beyond the top names it adds exposure GGHCX doesn't have.
Which is cheaper, GGHCX or JEHSX?
JEHSX has the lower expense ratio (1.04%).
Should I own both GGHCX and JEHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.